Century Therapeutics (IPSC) Other Non-Current Liabilities (2024 - 2026)
Century Therapeutics (IPSC) posted quarterly Other Non-Current Liabilities of $1.9 million for Q1 2026, down 77.19% year-over-year from $8.5 million in Q1 2025, and down 48.39% quarter-over-quarter from $3.8 million in Q4 2025.
Century Therapeutics (IPSC) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Other Non-Current Liabilities for 3 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 77.19% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 77.19% YoY), while the FY2025 annual figure was $3.8 million, down 57.0% from the prior year.
- Other Non-Current Liabilities declined to $1.9 million in Q1 2026 per IPSC's latest filing, from $3.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $9.3 million in Q2 2024 and bottomed at $20000.0 in Q1 2024.
- Historically, Other Non-Current Liabilities has averaged $6.6 million across 3 years, with a median of $8.7 million in 2024.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities surged 42400.0% — and 2026, when it plunged 77.19%.
- Century Therapeutics' Other Non-Current Liabilities stood at $8.7 million in 2024, then slumped by 57.0% to $3.8 million in 2025, then slumped by 48.39% to $1.9 million in 2026.
- Business Quant data shows IPSC's Other Non-Current Liabilities at $1.9 million in Q1 2026, $3.8 million in Q4 2025, and $9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 666,000.00 |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 9.31 Mn |
| Mar 31, 2024 | 20,000.00 |